<DOC>
	<DOCNO>NCT00168493</DOCNO>
	<brief_summary>We aim determine patient depression elevate risk development coronary heart disease , resolve whether severity patient 's depression counterpart demonstrable abnormality brain chemistry . Studies complete 28 patient depression ; male female . Patients study untreated administration selective serotonin re-uptake inhibitor ( SSRI ) antidepressant . They either newly diagnose depression , untreated patient suffer recent relapse , patient seek switch non-SSRI antidepressant due non-response . The turnover chemical messenger brain estimate high internal jugular venous blood sample DNA isolate examine blood cell . Immune function also assess . Whole body cardiac sympathetic nervous activity determine , well microneurographic record muscle sympathetic nervous activity . It hypothesise patient depression exist demonstrable cardiac disease demonstrate : Alterations brain monoaminergic neurotransmitter turnover , result sympathetic nervous activation dysregulation baroreflex control heart ( vagal ) muscle vasoconstrictor sympathetic nerve ; Exhibit enhance platelet reactivity predispose thrombogenesis myocardial ischaemia . Therapeutic intervention SSRI modify cardiac sympathetic function , baroreflex sensitivity platelet reactivity fashion likely reduce cardiac risk .</brief_summary>
	<brief_title>The Neurobiology Depressive Illness</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Major depression heart disease diabetes hypertension psychosis significant suicidal risk dementia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Major Depression</keyword>
	<keyword>Cardiac disease</keyword>
</DOC>